-
COST-UTILITY ANALYSIS OF [177LU]PSMA THERAPY COMPARED TO CABAZITAXEL IN PATIENTS WITH MCRPC FROM THE PERSPECTIVE OF THE COLOMBIAN HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
ASSESSING THE BURDEN OF HIDRADENITIS SUPPURATIVA AND THE INFLUENCE OF SOCIAL DETERMINANTS OF HEALTH ON PATIENT-REPORTED QUALITYOF LIFE
Mar 18, 2026, 21:38 PM -
DOES ARTIFICIAL INTELLIGENCE IMPROVE OUTCOMES IN ACUTE ISCHEMIC STROKE CARE?
Mar 18, 2026, 21:38 PM -
DELAYS AND DENIALS FOR BRANDED MEDICATION FILLS DUE TO PRIOR AUTHORIZATION
Mar 18, 2026, 21:38 PM -
A REVIEW ON THE APPLICATION OF PATIENT-REPORTED OUTCOMES IN THE LABELING OF NEW ONCOLOGY DRUGS
Mar 18, 2026, 21:38 PM -
BUDGET IMPACT MODEL OF LONAPEGSOMATROPIN FOR THE TREATMENT OF ADULT GROWTH HORMONE DEFICIENCY IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
HARNESSING AGENTIC AI FOR COHORT IDENTIFICATION: A CASE STUDY IN CLL/SLL PATIENTS TREATED WITH BTK INHIBITORS AT A US ACADEMIC HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
HEALTH-RELATED QUALITY OF LIFE AND HEALTH STATE UTILITY VALUES IN MODERATE TO VERY SEVERE COPD: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
COST-CONSEQUENCE ANALYSIS OF UPADACITINIB FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS IN COLOMBIA
Mar 18, 2026, 21:38 PM -
COMPARATIVE RISK OF SUICIDAL IDEATION AND SELF-HARM AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH BREXPIPRAZOLE VERSUS OTHER ORAL ATYPICAL ANTIPSYCHOTICS: A PROPENSITY SCORE-MATCHED COHORT ANALYSIS
Mar 18, 2026, 21:38 PM -
ECONOMIC EVALUATION OF DIABETES MANAGEMENT STRATEGIES: INSIGHTS FROM PATIENT GLUCOSE CONTROL TRAJECTORIESLITHUANIAN NATIONAL HEALTH INSURANCE FUND'S ADMINISTRATIVE DATA
Mar 18, 2026, 21:38 PM -
COMPARATIVE CARDIOVASCULAR AND KIDNEY EFFECTIVENESS OF GLP-1 RECEPTOR AGONISTS VERSUS OTHER GLUCOSE-LOWERING AGENTS IN PATIENTS WITH TYPE 2 DIABETES: A REAL-WORLD STUDY IN CHINA
Mar 18, 2026, 21:38 PM -
AUTHOR
Mar 18, 2026, 21:38 PM -
ASSESSING ACCESS TO INNOVATIVE ORPHAN MEDICINES IN LATIN AMERICA: A CROSS-COUNTRY VALUE AND ACCESS ANALYSIS
Mar 18, 2026, 21:38 PM -
A QUALITATIVE STUDY TO EXPLORE PATIENT PERSPECTIVES ON FUTURE GENE THERAPY FOR LIMB GIRDLE MUSCULAR DYSTROPHY (LGMD) SARCOGLYCANOPATHY SUBTYPES 2E/R4, 2D/R3, AND 2C/R5
Mar 18, 2026, 21:38 PM -
VARIABILITY IN DRUG-DRUG INTERACTION DATABASES AND ITS IMPLICATIONS FOR CLINICAL DECISION SUPPORT SYSTEMS: A CROSS-SECTIONAL STUDY FROM A TERTIARY CARE HOSPITAL IN INDIA
Mar 18, 2026, 21:38 PM -
PATIENT-MODIFIABLE RISK FACTORS FOR ANASTOMOTIC LEAK IN COLORECTAL SURGERY: A SCOPING REVIEW
Mar 18, 2026, 21:38 PM -
DR. TAORAN LIU
Mar 18, 2026, 21:38 PM -
CONSENSUS ON BARRIERS AND UNMET NEEDS IN HEMOPHILIA CARE IN BRAZIL: A MODIFIED DELPHI STUDY
Mar 18, 2026, 21:38 PM -
HEALTHCARE EXPENDITURE AMONG INDIVIDUALS LIVING WITH ALZHEIMER’S DISEASE: A JAPANESE PUBLIC HEALTHCARE PERSPECTIVE
Mar 18, 2026, 21:38 PM
